Officials with the U.S. Food and Drug Administration have officially escalated a chocolate recall initially issued in ...

The drug offered more relief than a placebo in clinical trials, though it does not appear more effective than other pain ...

There is no evidence that a senior Food and Drug Administration (FDA) worker was arrested after samples of the H5N1 bird flu virus were found in his fridge. The narrative stems from a website whose ...

President Donald Trump has nominated Kennedy to be the secretary of the U.S. Department of Health and Human Services, which ...

( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults.

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...

Plus, NBC News spoke to trans service members about their thoughts on President Trump's executive order banning trans people from enlisting and serving in the military.

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

A new type of non-opioid painkiller, aimed at treating short-term pain in adults, has been approved by the US Food and Drug Administration (FDA). The drug suzetrigine, known by its brand name Journavx ...

With little fanfare, the Biden administration stacked a critical committee that helps set U.S. vaccination policy with new ...

(CNN) – The U.S. Food and Drug Administration approved the first new type of pain medication in more than two decades, and it’s not an opioid. The drug is suzetrigine under the brand name Journavx. It ...